Murdannia loriformis
Murdannia loriformis · Accepted scientific name
Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆
Murdannia loriformis is a medicinal plant that has gained significant attention for its potential bioactive properties. Recent scientific investigations have focused on its 80% ethanol extract to evaluate its biological effects. Studies often utilize specific chemical models, such as Methylazoxymethanol Acetate and N-Methyl-N'-nitro-N-nitrosoguanidine, to test its efficacy. By analyzing these extracts under controlled conditions, researchers aim to uncover the plant's therapeutic potential. This ongoing research provides critical insights into how the various preparations of this plant interact with complex biological systems.
- Synonyms
- Aneilema Loriforme · Aneilema Nudiflorum Var. Terminale · 4 more
- Common names
- Not available
- Family
- Commelinaceae
- Distribution
- Not available
- Plant Parts
- Not available
Classification
Common Names
Murdannia loriformis is a versatile plant recognized by a variety of distinct regional names across different cultures. In Thailand, it is affectionately known by the common names niu e cao and หญ้าปักกิ่ง. Moving toward East Asia, the species is identified in Japan as シマイボクサ. It also carries significant linguistic weight in Chinese-speaking regions, where it is called 牛軛草 or 牛轭草. These diverse naming conventions highlight the widespread presence and botanical importance of this unique species.
Sources: Catalogue of Life (COL)
Synonyms
Murdannia loriformis is a plant species that has been documented under several different botanical names throughout history. In various taxonomic records, it is recognized by the synonyms Aneilema angustifolium and Aneilema loriforme. The species is also frequently associated with the name Aneilema terminale in scientific literature. Furthermore, its classification includes specific varieties such as Aneilema nudiflorum var. rigidior and Aneilema nudiflorum var. terminale. Understanding these various synonyms is essential for researchers tracking the plant's identity across different studies.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Murdannia loriformis belongs to the vast kingdom Plantae, representing a diverse branch of the living world. Within this kingdom, the plant is classified under the class Equisetopsida. It further falls into the order Commelinales, which helps define its evolutionary lineage. As a member of the genus Murdannia, it shares specific morphological traits with its close relatives. Finally, this species is a distinct part of the Commelinaceae family.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Commelinales |
| Family | Commelinaceae |
| Genus | Murdannia |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Murdannia loriformis is widely distributed across various temperate regions of Asia. In China, this plant can be found in diverse locations including South-Central, Southeast, and the island of Hainan. Its presence also extends into the high-altitude landscapes of Tibet. Beyond mainland China, the species is successfully established in Eastern Asia, specifically within Japan. These varied geographic ranges highlight the plant's ability to thrive in multiple Asian environments.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Murdannia loriformis grows in a distinct herb form, spreading naturally across its environment. As a self-supporting plant, it maintains its own structure without the need for external assistance.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Compounds
Conditions
Murdannia loriformis exhibits significant antimutagenic activity against several specific chemical compounds in the Salmonella mutation assay. Specifically, the plant extract treats 2-(2-furyl)-3-(5-nitro-2-furyl) acrylamide by reducing its mutagenicity. It also effectively treats 2-amino-1,4-dimethyl-5H-pyrido[4,3-b]indole and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Furthermore, the extract demonstrates the ability to treat 2-amino-3,4-dimethylimidazo[4,5-f]quinoline and 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline. These interactions contribute to the overall cancer chemopreventive properties observed in the medicinal plant.
Preparations
Murdannia loriformis is prepared as an 80% ethanol extract to investigate its potential antimutagenic and cancer chemopreventive activities. This specific 80% ethanol extract of the Thai medicinal plant was tested for its ability to reduce the mutagenicity of various compounds in a Salmonella mutation assay. Furthermore, Murdannia loriformis is prepared as an extract to evaluate its impact on aberrant crypt focus formation in the colons of F344 rats. Research also shows that Murdannia loriformis extract is utilized to modulate serum aflatoxin-albumin adduct levels following exposure to aflatoxin B(1). These studies collectively highlight the diverse pharmacological assessments performed using different preparations of the plant extract.